Label: DERMOSCRIBE PSORIASIS- liquor carbonis detergens, salicylic acid cream

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated December 22, 2022

If you are a consumer or patient please visit this version.

View All Sections
  • ACTIVE INGREDIENTS

    LIQUOR CARBONIS DETERGENS 5%, Salicylic Acid 3%

  • PURPOSE

    TREATMENT OF PSORIASIS.

  • USE

    Dermoscribe's Psoriasis Cream is a topical treatment for relief of Psoriasis.

  • WARNINGS

    FOR EXTERNAL USE ONLY. 

    Seek medical advice before using if pregnant or breastfeeding. If irritation
    develops, stop using and seek medical advice. May not be as effective after expiry date.

  • KEEP OUT OF REACH OF CHILDREN

    KEEP OUT OF REACH OF CHILDREN.

  • DIRECTIONS

    For use only by persons over 12 years old. Apply in a thin layer over the affected area once or twice daily as required.

    Use only in accordance with the directions on the label and within the packaging. Refer to enclosed leaflet for detailed directions.

  • INACTIVE INGREDIENTS

    AQUEOUS CREAM

  • OTHER SAFETY INFORMATION

    STORE AT ROOM TEMPERATURE

  • PRINCIPAL DISPLAY PANEL

    Dermoscribe Psoriasis Cream

  • INGREDIENTS AND APPEARANCE
    DERMOSCRIBE PSORIASIS 
    liquor carbonis detergens, salicylic acid cream
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:69683-201
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    COAL TAR (UNII: R533ESO2EC) (COAL TAR - UNII:R533ESO2EC) COAL TAR5 g  in 100 g
    SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID3 g  in 100 g
    Inactive Ingredients
    Ingredient NameStrength
    WATER (UNII: 059QF0KO0R)  
    CARBOMER HOMOPOLYMER TYPE C (UNII: 4Q93RCW27E)  
    MINERAL OIL (UNII: T5L8T28FGP)  
    GLYCOL STEARATE (UNII: 0324G66D0E)  
    SORBITOL (UNII: 506T60A25R)  
    CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    COCONUT OIL (UNII: Q9L0O73W7L)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    POLYSORBATE 20 (UNII: 7T1F30V5YH)  
    SODIUM HYDROXIDE (UNII: 55X04QC32I)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:69683-201-1160 g in 1 BOTTLE; Type 0: Not a Combination Product02/21/2016
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph finalpart358H02/21/2016
    Labeler - DERMOSCRIBE PTY LTD (742164734)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!